Improvement in hepatic insulin sensitivity after Roux-en-Y gastric bypass in a rat model of obesity is partially mediated via hypothalamic insulin action
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Roux-en-Y gastric bypass (RYGB) surgery, an effective treatment for morbid obesity, commonly leads to near complete resolution of type 2 diabetes. The underlying mechanisms, however, remain unclear and factors other than weight loss alone may be involved.
To determine whether increased hypothalamic insulin sensitivity after RYGB drives the rapid improvement in glucose metabolism, high-fat-fed rats received either an insulin receptor (IR) antisense vector or a control lentiviral vector that was microinjected into the ventromedial hypothalamus (VMH). Six weeks later, rats underwent RYGB or control gastrointestinal surgery.
Four weeks after surgery, weight loss was comparable in RYGB and surgical controls. Nevertheless, only RYGB rats that received the control vector demonstrated both improved hepatic and peripheral insulin sensitivity. Insulin suppressed hepatic glucose production (HGP) by 50% (p < 0.05) with RYGB, whereas the effect of insulin on HGP was completely absent in VMH IR knockdown (IRkd) rats. By contrast, both RYGB groups displayed an identical twofold increase in insulin-stimulated peripheral glucose uptake. The animals that underwent control gastrointestinal surgery failed to show any improvement in either hepatic or peripheral insulin sensitivity; VMH IRkd did not influence the magnitude of insulin resistance.
Our findings demonstrate that RYGB surgery in high-fat-fed obese rats enhances hepatic and peripheral insulin sensitivity independently of weight loss. The improved hepatic, but not the peripheral, response to insulin is mediated centrally at the level of the VMH. These data provide direct evidence that the metabolic benefits of RYGB surgery are not simply a consequence of weight loss but likely in part involve the central nervous system.
- Levin BE, Routh VH, Kang L, Sanders NM, Dunn-Meynell AA (2004) Neuronal glucosensing: what do we know after 50 years? Diabetes 53:2521–2528 CrossRef
- Sherwin RS (2008) Bringing light to the dark side of insulin: a journey across the blood–brain barrier. Diabetes 57:2259–2268 CrossRef
- Cotero VE, Zhang BB, Routh VH (2010) The response of glucose-excited neurones in the ventromedial hypothalamus to decreased glucose is enhanced in a murine model of type 2 diabetes mellitus. J Neuroendocrinol 22:65–74 CrossRef
- Lin HV, Plum L, Ono H et al (2010) Divergent regulation of energy expenditure and hepatic glucose production by insulin receptor in AgRP and POMC neurons. Diabetes 59:337–346 CrossRef
- Paranjape SA, Chan O, Zhu W et al (2011) Chronic reduction of insulin receptors in the ventromedial hypothalamus produces glucose intolerance and islet dysfunction in the absence of weight gain. Am J Physiol 301:E978–E983
- Varela JE (2011) Bariatric surgery: a cure for diabetes? Curr Opin Clin Nutr Metab Care 14:396–401 CrossRef
- Wickremesekera K, Miller G, Naotunne TD, Knowles G, Stubbs RS (2005) Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg 15:474–481 CrossRef
- Ochner CN, Gibson C, Carnell S, Dambkowski C, Geliebter A (2010) The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity. Physiol Behav 100:549–559 CrossRef
- Sandoval D (2011) Bariatric surgeries: beyond restriction and malabsorption. Int J Obes (Lond) 35(Suppl 3):S45–S49 CrossRef
- Thanos PK, Subrize M, Delis F et al (2012) Gastric bypass increases ethanol and water consumption in diet-induced obese rats. Obes Surg 22:1884–1892 CrossRef
- Improvement in hepatic insulin sensitivity after Roux-en-Y gastric bypass in a rat model of obesity is partially mediated via hypothalamic insulin action
Volume 56, Issue 9 , pp 2055-2058
- Cover Date
- Print ISSN
- Online ISSN
- Springer Berlin Heidelberg
- Additional Links
- Gastric bypass surgery
- Industry Sectors
- Author Affiliations
- 1. Department of Internal Medicine, Yale School of Medicine, New Haven, CT, 06520, USA
- 2. Milton Hershey School of Medicine, Penn State University, Hershey, PA, USA